Press, Events & Newsletters

Tunnell Consulting is proud to announce new additions to our leadership team as well as the establishment of collaborative and engaging partnerships.

Outsourced Pharma–Navigating an Ocean of Drug Development and Manufacturing Outsourcing

Julia O’Neill to Moderate Session on “Audits and Inspections: Gaining Unparalleled Insights Into Your CDMO”

Tunnell Consulting Summer Newsletter – 2018

Outsourced Pharma–Fundamentals for Outsourcing Drug Development and Manufacturing

Kip Wolf to Moderate Session on “Negotiating Strategies for Quality and Supply Agreements”

Process Validation Summit 2018

Julia O’Neill to Deliver Case Study on “Control Strategy for Cell & Gene Therapy Products”

Outsourced Pharma–Thriving in An Expanded Outsourced Drug Development and Manufacturing Model

Julia O’Neill to Moderate Session on “Help! The 7 Critical Areas Where Sponsors Need More Support”

Tunnell Consulting Inaugural Newsletter – 2018

Tunnell Consulting Shares Thought Leadership in 3 Leading Industry Events

Tunnell Principal and Statistician Julia O’Neill to Speak/Moderate on Important Biopharm Topics

2018 Life Sciences Pennsylvania Annual Dinner

Tunnell and Turesol Members to Attend Dinner

Tunnell Consulting and its sister company, Turesol Staffing Solutions, leads development of ISPE’s Process Capability Maturity Model (PCMM)

Tunnell Consulting’s Julia O’Neill Presents at 2017 PDA Cell and Gene Therapy Conference

Julia will deliver a presentation on Developing control strategy for gene and cell therapies – Journey of unique challenges. We hope to see you

ISPE Annual Conference

Four Tunnell Consultants to Contribute to Innovative and Educational Sessions

61st Annual Fall Technical Conference

Tunnell Principal and Statistician Julia O’Neill to Speak on “Saving Lives With Statistics: A Framework for Statistical Applications in Pharmaceutical Manufacturing and Development”

Tunnell Consulting’s Julia O’Neill Presents at Fall Technical Conference

Session highlights a major shift in discovery of life-changing medicines, and the increasingly important role of statistics in development and manufacturing. We hope to

Tunnell Consulting Joins Top Industry Experts at ISPE Conference

Tunnell Consulting experts bring thought leadership on driving innovation to advancing patient therapies at key industry event. We hope to see you at the

Information Governance Pharmaceutical Roundtable

Kip Wolf to speak “The State of Information Governance in the Biopharmaceutical Industry”.

Tunnell Consulting’s Julia O’Neill Named to Editorial Advisory Board of Outsourced Pharma

In this week’s Outsourced Pharma, chief editor Louis Garguilo announced that Tunnell’s Julia O’Neill is among a small and exclusive group to join the

Tunnell Consulting’s Kip Wolf Delivers Insights into the Future of Pharmaceuticals Industry

Industry visionary Kip Wolf provides clarity, insights and innovative solutions to the changes and challenges of the pharma industry.

Tunnell Consulting Strengthens Regulatory Affairs Team With Addition of Industry Veteran Kati Abraham

Abraham’s extensive insight and experience guides life sciences companies successfully through the regulatory process.

Julia O’Neill of Tunnell Consulting Shares Process Validation Insights at Pharma Conference

“Pharmaceutical companies must modernize their validation and risk management approaches.”

Process Validation Summit 2017

Julia O’Neill will “explore alternative approaches for specification setting, and reconnect specific strategies for both traditional and accelerated validation” during her presentation on The

Tunnell Consulting Launches Staffing Business Unit

“Turesol is designed and prepared to respond to those temporary resource needs with speed and competitive pricing.”

Outsourced Pharma – Boston

Julia O’Neill, Principal and statistician, will be a member of a panel discussing “Winning Workforce: A New Generation in the Supply Chain” at the

Regulatory Sciences for Biologics & Vaccines – Leesburg, VA

Julia O’Neill, Principal and statistician, will discuss “Lifecycle Approach to Validation Supports Accelerated Approvals” at the upcoming Regulatory Sciences for Biologics and Vaccines Conference

Conrad J. Heilman, Jr., Ph.D., Retires from Tunnell Consulting

“The only constant is change.”
Scroll to Top